Immutep (ASX:IMM) has announced the appointment of Lucy Turnbull AO as a non-executive director.
Ms Turnbull rejoins Immutep’s board having previously served as its chair from October 2010 to November 2017.
Since then, Ms Turnbull has remained close to the company and following the recent passing of Grant Chamberlain, has agreed to replace him as a non-executive director.
Ms Turnbull is a distinguished Australian businesswoman, philanthropist and former local government politician. With a background in commercial law and investment banking, she was the first female Lord Mayor of the City of Sydney from 2003 to 2004 and has served on the boards of the NSW Cancer Institute, the Sydney Children’s Hospital Foundation, the Sydney Cancer Centre and the Sydney Festival.
In 2011, Ms Turnbull was appointed an Officer of the Order of Australia for her service to the community, local government and business, including through her philanthropic contributions and fundraising for a range of medical, social welfare, educational, youth and cultural organisations.
“It is a pleasure to welcome Lucy back to the Immutep Board,” said chairman Dr Russell Howard. “The Company is at an incredibly exciting juncture given its clinical results in multiple cancer indications and growing global recognition as the leader in LAG-3 immuno-therapy. With Lucy’s business acumen, passion for innovative cancer treatments and extensive knowledge of the Company, her contribution will be wide-reaching and most valued.”
“As a shareholder and longstanding supporter, I have followed Immutep closely in the intervening years and it has been marvellous to see so much achieved by the talented team who I am delighted to be working with again. Immutep is an exceptionally promising biotech with innovative technology that could deliver a meaningful benefit to many cancer patient groups around the world,” added Ms Turnbull.
